Imaging use rates vary by region
Utilization rates of CT, MRI, and PET for the Medicare population vary substantially from region to region with Atlanta having the highest rate and Seattle having the lowest, according to a study in the April issue of the American Journal of Roentgenology.
Utilization rates of CT, MRI, and PET for the Medicare population vary substantially from region to region with Atlanta having the highest rate and Seattle having the lowest, according to a study in the April issue of the American Journal of Roentgenology.
Researchers calculated the overall diagnostic imaging procedure utilization rate based on data from the Centers for Medicare and Medicaid Services Physician Supplier Procedure Summary Files for 1998-2007. In 2007 Atlanta had the highest utilization rate with 4.6 procedures per capita compared with 3.47 in 1998. In 2007 Seattle had the lowest utilization rate with 2.99 procedures per capita compared with 2.33 in 1998.
“Wide geographic variation in utilization raises questions about underutilization and quality on the low side and overutilization and costs on the high side,” said Laurence Parker, Ph.D., lead author of the study and director of Health Services and Outcome Research at Thomas Jefferson University Hospital in Philadelphia.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
